LXXGF News and Press, Lexagene Holdings From 09/09/20

BEVERLY, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc.  (TSX VENTURE: LXG) (OTCQB: LXXGF) (" LexaGene " or the " Company ") is pleased to announce that it has closed its previously announced offering of units (the “ Units ”) for aggregate gro...

With the increase in demand for Personal Protective Equipment as well as other medical supplies, especially for the frontline workers who risk their lives every day during this pandemic period, many well-meaning innovators around the world have taken this up as an opportunity to help out by ma...

As your drug patent rights lapse, you can lose billions of money as your new competitors enter the market. This is the main reason why several investors always put their concentration on drug patent rights during the evaluation of drug companies. To help you make better investment decisions, h...

Scientists from the University of California, Irvine (“UCI”) are soon coming up with a rapid COVID-19 test that could give you your results in hours. The technology which relies on lab-on-a-chip model will also be cost-effective for you. The antibody testing COVID-19 diagnostic t...

Several tests have been developed to determine heart attack risks, some of which have been successful. Still, new tests are being developed, with the latest being a blood test used to determine whether the patient has had a blood attack. However, researchers have noted that the existing blood ...

One of the viruses that have the potential of spreading fastest from one person to the other is Ebola. Ebola outbreaks have been experienced in the recent past, especially in multiple African countries. For these outbreaks to stop, there is a need to develop a quick detection method for the di...

LexaGene Holdings ( OTCQB:LXXGF ) increases its bought deal to 13.6M units from the previously announced 8.82M, for the gross proceeds of ~C$11.56M. More news on: LexaGene Holdings Inc., , Healthcare stocks news, Read more ...

LexaGene Announces an Increase to Previously Announced Bought Deal Public Offering Canada NewsWire BEVERLY, Mass., Aug. 19, 2020 /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DIS...

LexaGene Holdings ( OTCQB:LXXGF ) entered into an agreement with underwriters - Canaccord Genuity and Industrial Alliance Securities - for purchase, on a bought deal basis, 8.82M units of the company at C$0.85/unit. More news on: LexaGene Holdings Inc., Healthcare stocks news, , Read...

LexaGene Announces $7.5 Million Bought Deal Public Offering Canada NewsWire BEVERLY, MA, Aug. 18, 2020 /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED ...